New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 2, 2014
07:58 EDTZMHZimmer price target raised to $131 from $110 at Canaccord
Canaccord raised its price target on Zimmer Holdings to $131 from $110 to reflect the acquisition of Biomet. The firm sees a massive new knee product cycle and believes Zimmer is positioned solidly in the global musculoskeletal and OrthoRecon industry. Canaccord maintains its Buy rating on the stock.
News For ZMH From The Last 14 Days
Check below for free stories on ZMH the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 22, 2014
08:15 EDTZMHZimmer should be bought on any weakness from Q2 results, says RBC Capital
RBC Capital believes that consensus Q2 recon estimates for Zimmer may be "a bit optimistic," but the firm thinks that investors already partially anticipate a miss on that metric The firm recommends buying the stock on any weakness associated with Q2 results, as it thinks the company's valuation is favorable, given its growth outlook. RBC Capital keeps a $120 price target and Outperform rating on the shares.
July 10, 2014
09:06 EDTZMHBofA/Merrill remains bullish on Zimmer
BofA/Merrill said BMET reported solid Q4 results, which bode well for Zimmer (ZMH). The firm rates ZImmer a Buy with a $125 price target and a best idea.
06:42 EDTZMHBiomet reports Q4 net sales up 7.7% to $844.5M
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use